Publicaciones en colaboración con investigadores/as de Emory University (5)

2022

  1. Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy

    Acta Neuropathologica, Vol. 144, Núm. 2, pp. 241-258

2018

  1. Translating molecular advances in Down syndrome and Fragile X syndrome into therapies

    European Neuropsychopharmacology, Vol. 28, Núm. 6, pp. 675-690

2009

  1. Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and its enantiomers in mice: Pharmacokinetic considerations

    Journal of Pharmacology and Experimental Therapeutics, Vol. 329, Núm. 3, pp. 1006-1015

2005

  1. Neurotoxicity of MDMA (ecstasy): Beyond metabolism (multiple letters)

    Trends in Pharmacological Sciences

  2. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain

    Journal of Pharmacology and Experimental Therapeutics, Vol. 313, Núm. 1, pp. 422-431